Chemed management to meet with Oppenheimer
PremiumThe FlyChemed management to meet with Oppenheimer
2M ago
Chemed raises FY24 adjusted EPS view to $23.55-$23.80 from $23.30-$23.70
Premium
The Fly
Chemed raises FY24 adjusted EPS view to $23.55-$23.80 from $23.30-$23.70
4M ago
Chemed reports Q2 adjusted EPS $5.47, consensus $5.59
Premium
The Fly
Chemed reports Q2 adjusted EPS $5.47, consensus $5.59
4M ago
Chemed backs FY24 adjusted EPS view $23.30-$23.70, consensus $23.52
PremiumThe FlyChemed backs FY24 adjusted EPS view $23.30-$23.70, consensus $23.52
7M ago
Chemed reports Q1 adjusted EPS $5.20, consensus $5.48
Premium
The Fly
Chemed reports Q1 adjusted EPS $5.20, consensus $5.48
7M ago
CHE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CHE Upcoming Earnings Report: What to Expect?
7M ago
Is CHE a Buy, Before Earnings?
PremiumPre-EarningsIs CHE a Buy, Before Earnings?
9M ago
Chemed appoints Michael Witzeman as CFO, effective January 1
Premium
The Fly
Chemed appoints Michael Witzeman as CFO, effective January 1
11M ago
Chemed announces additional $300M for stock repurchase
Premium
The Fly
Chemed announces additional $300M for stock repurchase
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100